| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | ciliary membrane | 3.70e-04 | 98 | 30 | 3 | GO:0060170 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 9.61e-04 | 32 | 30 | 2 | GO:0043189 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 9.61e-04 | 32 | 30 | 2 | GO:0035267 | |
| Domain | MRG | 7.99e-06 | 3 | 31 | 2 | PS51640 | |
| Domain | MRG_dom | 7.99e-06 | 3 | 31 | 2 | IPR026541 | |
| Domain | MRG | 1.60e-05 | 4 | 31 | 2 | PF05712 | |
| Domain | MRG | 1.60e-05 | 4 | 31 | 2 | IPR008676 | |
| Domain | TBC_RABGAP | 3.75e-03 | 55 | 31 | 2 | PS50086 | |
| Domain | Rab-GTPase-TBC_dom | 3.75e-03 | 55 | 31 | 2 | IPR000195 | |
| Domain | - | 5.83e-03 | 222 | 31 | 3 | 1.25.10.10 | |
| Domain | ARM-like | 9.96e-03 | 270 | 31 | 3 | IPR011989 | |
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 15758025 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 9.56e-05 | 857 | 31 | 6 | 25609649 | |
| Pubmed | 2.10e-04 | 24 | 31 | 2 | 33705438 | ||
| Pubmed | 2.61e-04 | 653 | 31 | 5 | 22586326 | ||
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 2.86e-04 | 28 | 31 | 2 | 27002738 | |
| Pubmed | 3.29e-04 | 30 | 31 | 2 | 27568566 | ||
| Pubmed | Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus. | 3.84e-04 | 159 | 31 | 3 | 34578187 | |
| Pubmed | 4.43e-04 | 167 | 31 | 3 | 25659891 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 4.78e-04 | 1155 | 31 | 6 | 20360068 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 6.07e-04 | 440 | 31 | 4 | 34244565 | |
| Pubmed | 6.47e-04 | 42 | 31 | 2 | 27578003 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 7.70e-04 | 202 | 31 | 3 | 33005030 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 3.91e-04 | 211 | 31 | 3 | chr1p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq22 | 6.04e-03 | 172 | 31 | 2 | chrXq22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q23 | 1.02e-02 | 226 | 31 | 2 | chr1q23 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.12e-02 | 163 | 18 | 2 | 590 | |
| Coexpression | DAUER_STAT3_TARGETS_DN | 2.50e-05 | 48 | 31 | 3 | M13696 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP | 8.64e-05 | 199 | 31 | 4 | M3639 | |
| Coexpression | GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 8.64e-05 | 199 | 31 | 4 | M5359 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN | 8.81e-05 | 200 | 31 | 4 | M5081 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN | 8.81e-05 | 200 | 31 | 4 | M9588 | |
| Coexpression | IBRAHIM_NRF1_UP | 1.24e-04 | 420 | 31 | 5 | M42509 | |
| ToppCell | PBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 1.71e-04 | 156 | 31 | 3 | 9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.95e-04 | 163 | 31 | 3 | d005115aa1e1458b51de7eb719794617a4168608 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-04 | 170 | 31 | 3 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | 10x5'-blood-Lymphocytic_B_plasma-Plasmablasts|blood / Manually curated celltypes from each tissue | 2.40e-04 | 175 | 31 | 3 | 2e048bf7961c3d86b6e12a1ebae3b3f2359af457 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 2.48e-04 | 177 | 31 | 3 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 2.52e-04 | 178 | 31 | 3 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.56e-04 | 179 | 31 | 3 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | Mild-CD4+_T|World / Disease group and Cell class | 2.74e-04 | 183 | 31 | 3 | c4ac8893d38a3da4e19fe2ef1756bd69c89e975c | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.74e-04 | 183 | 31 | 3 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.82e-04 | 185 | 31 | 3 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | COVID-19_Moderate-NK_activated|World / disease group, cell group and cell class | 2.87e-04 | 186 | 31 | 3 | ff8f32f69516bf785224fa12f8139a95359b0279 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.96e-04 | 188 | 31 | 3 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | hematopoetic_progenitors-CD34+_MEP_1|World / Lineage and Cell class | 3.10e-04 | 191 | 31 | 3 | 91327184ca40bfb8c9e904991b1be503aaccd7bc | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.10e-04 | 191 | 31 | 3 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.10e-04 | 191 | 31 | 3 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | BAL-Mild|BAL / Compartment, Disease Groups and Clusters | 3.15e-04 | 192 | 31 | 3 | 1a6cbf014d3f7a3fb6f53adab078c4742e7137de | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Monocytic|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.15e-04 | 192 | 31 | 3 | 81f93b4c853f176c91b5ddef34238e37047a0e69 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.15e-04 | 192 | 31 | 3 | af453a179f3fdd4ae870f1d98a485e8c9fd726ac | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Myeloid-Monocytic-Nonclassical_Monocyte|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.15e-04 | 192 | 31 | 3 | 176b9c1dd2c91bca46e12fa5060bfe590dc18246 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 192 | 31 | 3 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | Mild_COVID-19|World / Disease group,lineage and cell class （2021.01.30） | 3.20e-04 | 193 | 31 | 3 | 325b0768827bf8701bfb7f686bb11fd8b1a41a5c | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 194 | 31 | 3 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-04 | 194 | 31 | 3 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-04 | 194 | 31 | 3 | 0e9830ad070c47acaa952400bf2a3ddbff664a2f | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.25e-04 | 194 | 31 | 3 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.30e-04 | 195 | 31 | 3 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|World / disease group, cell group and cell class | 3.30e-04 | 195 | 31 | 3 | 070c5d3bdbd4ea54a579c01c37fb99bcf823982e | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.30e-04 | 195 | 31 | 3 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.30e-04 | 195 | 31 | 3 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | CV-Moderate-1|Moderate / Virus stimulation, Condition and Cluster | 3.34e-04 | 196 | 31 | 3 | b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1 | |
| ToppCell | BAL-Mild|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.34e-04 | 196 | 31 | 3 | 6566e6671257f7df4d3f375e84f0b292ab4bcde1 | |
| ToppCell | C_05|World / shred on cell type and cluster | 3.34e-04 | 196 | 31 | 3 | bf4dfb460a153dbafb2b9b12b360c8757cec22cd | |
| ToppCell | BAL-Mild|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.34e-04 | 196 | 31 | 3 | 3408d561d29802fca9eff5c54ccf70818d240cea | |
| ToppCell | mild-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.34e-04 | 196 | 31 | 3 | ded44b38ea489946e9eedfe752b5a9fde9149c16 | |
| ToppCell | Mild|World / Disease group and Cell class | 3.34e-04 | 196 | 31 | 3 | 5e4ed4a5a437cfa002b92775992a791e27aa4c27 | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 3.34e-04 | 196 | 31 | 3 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | Mild-CD4+_T_activated|Mild / Disease group and Cell class | 3.34e-04 | 196 | 31 | 3 | daa1c3322d81e649161e889e1d78451d2d425d09 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 3.34e-04 | 196 | 31 | 3 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.40e-04 | 197 | 31 | 3 | b3876076684781fb8384117f2cf367d828985986 | |
| ToppCell | CV-Moderate-1|CV / Virus stimulation, Condition and Cluster | 3.40e-04 | 197 | 31 | 3 | e3d00d850b4d191f9592ef993c0eaadfe5710b5f | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.40e-04 | 197 | 31 | 3 | 0b4fdf0131dd67a86ee3209fa66db0ca2e01a10e | |
| ToppCell | severe-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.40e-04 | 197 | 31 | 3 | c8a90d82170cf20e14aebecddcf7cc0ca56cda87 | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 3.45e-04 | 198 | 31 | 3 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 3.45e-04 | 198 | 31 | 3 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 3.45e-04 | 198 | 31 | 3 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 3.50e-04 | 199 | 31 | 3 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 3.50e-04 | 199 | 31 | 3 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 3.50e-04 | 199 | 31 | 3 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 3.50e-04 | 199 | 31 | 3 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 3.55e-04 | 200 | 31 | 3 | deeed668b129e66156b5f6abe1a07a9bf842a14d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Macroglial-Glia_progenitor_cell|1m / Sample Type, Dataset, Time_group, and Cell type. | 3.55e-04 | 200 | 31 | 3 | 26940eee4a2f2aafd857964b5607e7dfb65f8d6f | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 3.55e-04 | 200 | 31 | 3 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.55e-04 | 200 | 31 | 3 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| Disease | Meckel syndrome (implicated_via_orthology) | 2.98e-05 | 8 | 31 | 2 | DOID:0050778 (implicated_via_orthology) | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 6.95e-04 | 37 | 31 | 2 | DOID:0050545 (implicated_via_orthology) | |
| Disease | systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis | 8.13e-04 | 40 | 31 | 2 | EFO_1001999, EFO_1002019, EFO_1002020 | |
| Disease | Influenza | 1.37e-03 | 52 | 31 | 2 | C0021400 | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 2.00e-03 | 63 | 31 | 2 | EFO_0000685, EFO_0007791, EFO_0009459 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FFEENLSKLFLHFKS | 641 | O60347 | |
| HFFLIEKKSHLASIF | 406 | P0CF97 | |
| KEKTFQFLHQFSRLL | 1081 | Q96NH3 | |
| FKTAKSLFLVLFLFA | 226 | P0DMS8 | |
| SIFLTLLSNFKTHLK | 506 | Q9Y6D6 | |
| DFAVSQFKHLSKLLL | 1086 | Q9P241 | |
| NLSAFNCLHKFAKDF | 1481 | Q9H1A4 | |
| LFKLFSEGLFSAKLF | 181 | Q14C86 | |
| HFFSLPFKKSLLAAL | 246 | Q7Z412 | |
| NLKALLKHFDLFLRF | 476 | Q8N5Y2 | |
| LHDFLKYLAKNSASL | 256 | Q15014 | |
| DSLFLKLDALSNFHF | 501 | O00566 | |
| HFPFIFNNLSKIKLL | 631 | Q9UII4 | |
| KKIFFNSLSLHASKL | 411 | Q9Y2V7 | |
| KNFAAFFSHILSLAS | 321 | Q86XA9 | |
| SLNEKRTFFHLSALK | 426 | Q9P2N7 | |
| LFFKLKNFKTAATFA | 1111 | P53621 | |
| HSFALVSLGFFKNLK | 386 | P14616 | |
| SLQAVAFFVLHFLKA | 151 | Q6UWJ8 | |
| KLSKDQFALAFHLIS | 276 | P42566 | |
| HLFIFRKSNFIFDKL | 311 | Q96RD6 | |
| AFALKALQFLHKLIS | 616 | Q5HYA8 | |
| FTKEAKLFSFLALLN | 911 | Q5K651 | |
| SALFLSHNLKFLAKF | 141 | P29622 | |
| HKFFAATSIVLFLNK | 256 | P19087 | |
| DFFALLFLGNHFTKI | 331 | Q9P291 | |
| FHLLFDFLAFKNDIS | 296 | Q96KA5 | |
| SAFDIKCLFNHFLKI | 296 | Q8N999 | |
| KQRFLFAKLFSHITS | 556 | Q9UMS5 | |
| GLSFDTLHSKLKAFL | 471 | Q9H0V1 | |
| KLRDAFFKFDTLNHS | 2001 | O15050 | |
| HSFLSNAFFLKVTAL | 141 | Q96RL6 |